COMMUNIQUÉS West-GlobeNewswire

CV Sciences, Inc. Pre-Announces Record Second Quarter 2018 Sales
25/07/2018
Company Expects to Report Sales of $12.3 Million, up 203% from the same quarter in 2017 Will Host Earnings Call on Wednesday, August 1, 2018 LAS VEGAS, July 25, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) ( [...]
Teladoc to Participate in Upcoming Investor Conference
25/07/2018
PURCHASE, NY, July 25, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE:TDOC), the global leader in virtual care, announced today that Mark Hirschhorn, chief operating officer and chief financial officer, will participate [...]
Scythian Chief Medical Officer Professor Michael Barnes Expands Global Influence as a Cannabis Key Opinion Leader
25/07/2018
TORONTO, July 25, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) today announced [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
25/07/2018
FIT Biotech Oy Company release July 25, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Grandevo® CG and Regalia® CG Approved by the California Department of Pesticide Regulation
25/07/2018
Innovative Tools for a New Era: Grandevo® CG and Regalia® CG Are Effective Tools for Controlling Economically Damaging Mites, Insect Pests and Plant Diseases and Boosting Yields and Quality for Cannabis DAVIS, Calif., [...]
OpGen Announces Date of Second Quarter 2018 Financial Results Conference Call
25/07/2018
GAITHERSBERG, Md., July 25, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that the Company will report financial results for the three and six months ended June 30, 2018 after close of the U.S. [...]
Imagin Medical Announces Stock Options Granted
25/07/2018
VANCOUVER, B.C. and BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) (the “Company”) announced today that, pursuant to the Company’s Stock Option [...]
OrthoPediatrics Corp. to Report Second Quarter 2018 Financial Results on August 8, 2018
25/07/2018
Conference Call to Discuss Results on August 9, 2018 at 8:00 a.m. ET WARSAW, Ind., July 25, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on [...]
Albireo Appoints Patrick Horn MD, PhD as Chief Medical Officer
25/07/2018
--- Pediatrician with extensive orphan drug development expertise --- --- Experience with multiple Phase 3 programs and FDA submissions --- BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a [...]
Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics
25/07/2018
CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced that it [...]
Nabriva Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
25/07/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa. and SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of [...]
Bespoke Extracts Supports Make a Difference Foundation’s Provision of Blanket Warming System for Patients in Treatment at Florida Cancer Specialists & Research Institute in West Palm Beach
25/07/2018
SUNNY ISLES, Fla., July 25, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB:BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, is pleased to announce its support of Make A [...]
Syntactx Announces Expansion of Regulatory Affairs Leadership Team
25/07/2018
Company Names Three Industry Veterans to Lead Regulatory Affairs Team: Marlene Barton, Vice President, Department Head; Chie Iwaishi, Senior Director; and Darlene Garner, Manager Appointments Reflect Company’s Enhanced [...]
Endocyte Announces Second Quarter 2018 Financial Results and Operational Update Call
25/07/2018
WEST LAFAYETTE, Ind., July 25, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company will [...]
Sientra to Present at the Canaccord 38th Annual Growth Stock Conference
25/07/2018
SANTA BARBARA, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of the management team are scheduled to present at the Canaccord 38 th [...]
Minerva Neurosciences Names Devin Smith Senior Vice President, General Counsel
25/07/2018
WALTHAM, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
INSYS Therapeutics to Report Second Quarter 2018 Results on Aug. 8
25/07/2018
PHOENIX, July 25, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced that [...]
Immune Design to Report Second Quarter 2018 Financial Results and Provide Corporate Update
25/07/2018
SEATTLE and SOUTH SAN FRANCISCO, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report [...]
Apixio Launches HCC Auditor, the First AI-Powered Risk Adjustment Auditing Solution
25/07/2018
50 percent of health plan coders claim that their organization reviews less than 10 percent of charts pulled for risk adjustment coding – putting organizations at financial and compliance risk SAN MATEO, Calif., July 25 [...]

Pages